CHIEF EXECUTIVE OFFICER
Wed, May 15, 2024
May 15
exercised or converted securities in DAWN
3,562 shares @ $0.00
Decreased holdings by -14.30%
Net across this filing: +1.90% (+12,126 shares)
Option Exercise
Sale tied to a same-time option exercise
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
DAWNDay One Biopharmaceuticals, Inc.
HealthcareBiotechnology